AGREEMENT AND PLAN OF MERGER DATED AS OF JANUARY 7, 2024 AMONG MERCK SHARP & DOHME LLC, HAWAII MERGER SUB, INC. AND HARPOON THERAPEUTICS, INC.Agreement and Plan of Merger • January 8th, 2024 • Harpoon Therapeutics, Inc. • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledJanuary 8th, 2024 Company Industry JurisdictionAGREEMENT AND PLAN OF MERGER (this “Agreement”), dated as of January 7, 2024, among MERCK SHARP & DOHME LLC, a New Jersey limited liability company (“Parent”), HAWAII MERGER SUB, INC., a Delaware corporation and a wholly owned subsidiary of Parent (“Merger Sub”), and HARPOON THERAPEUTICS, INC., a Delaware corporation (the “Company”).
SUPPORT AGREEMENTSupport Agreement • January 8th, 2024 • Harpoon Therapeutics, Inc. • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledJanuary 8th, 2024 Company Industry JurisdictionThis SUPPORT AGREEMENT (this “Agreement”), dated January 7, 2024, is by and among [•] (“Stockholder”), Merck Sharpe & Dohme LLC, a New Jersey limited liability company (“Parent”), and Hawaii Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (“Merger Sub”).